Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder / Yasmin L. Hurd en The American Journal of Psychiatry, Año 2019 - Vol. 176 - No. 11 (Noviembre)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2019 - Vol. 176 - No. 11 (Noviembre) . - pp. 911–922 Título : Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder : a double-blind randomized placebo-controlled trial Tipo de documento: texto impreso Autores: Yasmin L. Hurd, Autor ; Sharron Spriggs, Autor ; Julia Alishayev, Autor Fecha de publicación: 2020 Artículo en la página: pp. 911–922 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Trastorno por uso de opioides, Canabis, CBD Resumen: Despite the staggering consequences of the opioid epidemic, limited nonopioid medication options have been developed to treat this medical and public health crisis. This study investigated the potential of cannabidiol (CBD), a nonintoxicating phytocannabinoid, to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder. Link: ./index.php?lvl=notice_display&id=23088 [artículo] Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder : a double-blind randomized placebo-controlled trial [texto impreso] / Yasmin L. Hurd, Autor ; Sharron Spriggs, Autor ; Julia Alishayev, Autor . - 2020 . - pp. 911–922. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2019 - Vol. 176 - No. 11 (Noviembre) . - pp. 911–922 Etiquetas: Trastorno por uso de opioides, Canabis, CBD Resumen: Despite the staggering consequences of the opioid epidemic, limited nonopioid medication options have been developed to treat this medical and public health crisis. This study investigated the potential of cannabidiol (CBD), a nonintoxicating phytocannabinoid, to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder. Link: ./index.php?lvl=notice_display&id=23088

Molecular Genetics and New Medication Strategies for Opioid Addiction / Yasmin L. Hurd en The American Journal of Psychiatry, Año 2018 - Vol. 175 - No. 10 (Octubre)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 10 (Octubre) . - pp. 935-942 Título : Molecular Genetics and New Medication Strategies for Opioid Addiction Tipo de documento: texto impreso Autores: Yasmin L. Hurd, Autor ; Charles P. O’Brien, Autor Fecha de publicación: 2019 Artículo en la página: pp. 935-942 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Canabidiol, Drogadicción, Epigenética, Genética OPRM1, Opioide Resumen: The opioid epidemic is at the epicenter of the drug crisis, resulting in an inconceivable number of overdose deaths and exorbitant associated medical costs that have crippled many communities across the socioeconomic spectrum in the United States. Link: ./index.php?lvl=notice_display&id=18198 [artículo] Molecular Genetics and New Medication Strategies for Opioid Addiction [texto impreso] / Yasmin L. Hurd, Autor ; Charles P. O’Brien, Autor . - 2019 . - pp. 935-942. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 10 (Octubre) . - pp. 935-942 Etiquetas: Canabidiol, Drogadicción, Epigenética, Genética OPRM1, Opioide Resumen: The opioid epidemic is at the epicenter of the drug crisis, resulting in an inconceivable number of overdose deaths and exorbitant associated medical costs that have crippled many communities across the socioeconomic spectrum in the United States. Link: ./index.php?lvl=notice_display&id=18198

---

1 (1 - 2 / 2) Por página: 25 50 100 200